Literature DB >> 12805997

Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7.

Trevor J Bushell1, Gilles Sansig, Valerie J Collett, Herman van der Putten, Graham L Collingridge.   

Abstract

Eight subtypes of metabotropic glutamate (mGlu) receptors have been identified of which two, mGlu5 and mGlu7, are highly expressed at synapses made between CA3 and CA1 pyramidal neurons in the hippocampus. This input, the Schaffer collateral-commissural pathway, displays robust long-term potentiation (LTP), a process believed to utilise molecular mechanisms that are key processes involved in the synaptic basis of learning and memory. To investigate the possible function in LTP of mGlu7 receptors, a subtype for which no specific antagonists exist, we generated a mouse lacking this receptor, by homologous recombination. We found that LTP could be induced in mGlu7-/- mice and that once the potentiation had reached a stable level there was no difference in the magnitude of LTP between mGlu7-/- mice and their littermate controls. However, the initial decremental phase of LTP, known as short-term potentiation (STP), was greatly attenuated in the mGlu7-/- mouse. In addition, there was less frequency facilitation during, and less post-tetanic potentiation following, a high frequency train in the mGlu7-/- mouse. These results show that the absence of mGlu7 receptors results in alterations in short-term synaptic plasticity in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12805997      PMCID: PMC6009301          DOI: 10.1100/tsw.2002.146

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  18 in total

1.  Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus.

Authors:  Rebecca Klar; Adam G Walker; Dipanwita Ghose; Brad A Grueter; Darren W Engers; Corey R Hopkins; Craig W Lindsley; Zixiu Xiang; P Jeffrey Conn; Colleen M Niswender
Journal:  J Neurosci       Date:  2015-05-13       Impact factor: 6.167

Review 2.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

3.  Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu7 Positive Allosteric Modulator Tool Compound.

Authors:  Carson W Reed; Jacob J Kalbfleisch; Madison J Wong; Jordan P Washecheck; Ashton Hunter; Alice L Rodriguez; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2020-08-20       Impact factor: 4.345

4.  VU6010608, a Novel mGlu7 NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides.

Authors:  Carson W Reed; Kevin M McGowan; Paul K Spearing; Branden J Stansley; Hanna F Roenfanz; Darren W Engers; Alice L Rodriguez; Eileen M Engelberg; Vincent B Luscombe; Matthew T Loch; Daniel H Remke; Jerri M Rook; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2017-11-08       Impact factor: 4.345

5.  Bidirectional modulation of glutamatergic synaptic transmission by metabotropic glutamate type 7 receptors at Schaffer collateral-CA1 hippocampal synapses.

Authors:  Ricardo Martín; José Javier Ferrero; Andrea Collado-Alsina; Carolina Aguado; Rafael Luján; Magdalena Torres; José Sánchez-Prieto
Journal:  J Physiol       Date:  2018-01-25       Impact factor: 5.182

Review 6.  Allosteric modulation of metabotropic glutamate receptors.

Authors:  Douglas J Sheffler; Karen J Gregory; Jerri M Rook; P Jeffrey Conn
Journal:  Adv Pharmacol       Date:  2011

7.  Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults.

Authors:  Kwangsik Nho; Vijay K Ramanan; Emrin Horgusluoglu; Sungeun Kim; Mark H Inlow; Shannon L Risacher; Brenna C McDonald; Martin R Farlow; Tatiana M Foroud; Sujuan Gao; Christopher M Callahan; Hugh C Hendrie; Alexander B Niculescu; Andrew J Saykin
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders.

Authors:  Nicole M Fisher; Robert W Gould; Rocco G Gogliotti; Annalise J McDonald; Hana Badivuku; Susmita Chennareddy; Aditi B Buch; Annah M Moore; Matthew T Jenkins; W Hudson Robb; Craig W Lindsley; Carrie K Jones; P Jeffrey Conn; Colleen M Niswender
Journal:  Genes Brain Behav       Date:  2020-04-14       Impact factor: 3.449

Review 9.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

10.  Discovery of VU6005649, a CNS Penetrant mGlu7/8 Receptor PAM Derived from a Series of Pyrazolo[1,5-a]pyrimidines.

Authors:  Masahito Abe; Mabel Seto; Rocco G Gogliotti; Matthew T Loch; Katrina A Bollinger; Sichen Chang; Eileen M Engelberg; Vincent B Luscombe; Joel M Harp; Michael Bubser; Darren W Engers; Carrie K Jones; Alice L Rodriguez; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2017-09-01       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.